Id |
Subject |
Object |
Predicate |
Lexical cue |
T51845 |
0-7 |
CD |
denotes |
4.1.1.2 |
T81264 |
9-18 |
NNP |
denotes |
Rationale |
T56248 |
18-19 |
-COLON- |
denotes |
: |
T77485 |
20-32 |
JJ |
denotes |
Convalescent |
T80710 |
33-39 |
NN |
denotes |
plasma |
T37520 |
40-44 |
IN |
denotes |
from |
T57657 |
45-53 |
NNS |
denotes |
patients |
T22774 |
54-63 |
VBN |
denotes |
recovered |
T85435 |
64-68 |
IN |
denotes |
from |
T50571 |
69-77 |
NN |
denotes |
COVID-19 |
T48141 |
78-81 |
MD |
denotes |
can |
T93212 |
82-87 |
VB |
denotes |
treat |
T48287 |
88-96 |
NNS |
denotes |
patients |
T91679 |
97-101 |
IN |
denotes |
with |
T80666 |
102-108 |
JJ |
denotes |
severe |
T17217 |
109-117 |
NN |
denotes |
COVID-19 |
T94687 |
118-119 |
DT |
denotes |
A |
T22655 |
120-125 |
NN |
denotes |
pilot |
T19573 |
126-131 |
NN |
denotes |
study |
T23972 |
132-133 |
-LRB- |
denotes |
[ |
T55337 |
133-135 |
CD |
denotes |
11 |
T96728 |
135-136 |
-RRB- |
denotes |
] |
T92410 |
137-145 |
RB |
denotes |
recently |
T26265 |
146-149 |
VBZ |
denotes |
has |
T35997 |
150-162 |
VBN |
denotes |
investigated |
T92380 |
163-166 |
DT |
denotes |
the |
T38590 |
167-173 |
NN |
denotes |
safety |
T37156 |
174-177 |
CC |
denotes |
and |
T24661 |
178-184 |
NN |
denotes |
effect |
T94632 |
185-187 |
IN |
denotes |
of |
T56352 |
188-200 |
JJ |
denotes |
convalescent |
T65134 |
201-207 |
NN |
denotes |
plasma |
T64844 |
208-212 |
WDT |
denotes |
that |
T95987 |
213-220 |
VBP |
denotes |
contain |
T86655 |
221-229 |
NN |
denotes |
antibody |
T45118 |
230-236 |
NNS |
denotes |
levels |
T26321 |
237-243 |
JJR |
denotes |
higher |
T17226 |
244-248 |
IN |
denotes |
than |
T2522 |
249-250 |
CD |
denotes |
1 |
T48589 |
250-251 |
-COLON- |
denotes |
: |
T90182 |
251-254 |
CD |
denotes |
640 |
T89317 |
255-263 |
VBN |
denotes |
combined |
T28925 |
264-268 |
IN |
denotes |
with |
T68950 |
269-276 |
JJ |
denotes |
regular |
T58621 |
277-287 |
JJ |
denotes |
anti-viral |
T22929 |
288-294 |
NNS |
denotes |
agents |
T50644 |
295-298 |
CC |
denotes |
and |
T63224 |
299-307 |
JJ |
denotes |
standard |
T22041 |
308-318 |
JJ |
denotes |
supportive |
T89053 |
319-323 |
NN |
denotes |
care |
T94835 |
324-326 |
IN |
denotes |
on |
T20257 |
327-335 |
JJ |
denotes |
clinical |
T49329 |
336-344 |
NNS |
denotes |
outcomes |
T91601 |
345-347 |
IN |
denotes |
of |
T6238 |
348-351 |
CD |
denotes |
ten |
T3048 |
352-360 |
NNS |
denotes |
patients |
T18696 |
361-365 |
IN |
denotes |
with |
T93206 |
366-372 |
JJ |
denotes |
severe |
T71443 |
373-381 |
NN |
denotes |
COVID-19 |
T46997 |
383-386 |
DT |
denotes |
The |
T7672 |
387-392 |
NN |
denotes |
study |
T83098 |
393-399 |
VBD |
denotes |
showed |
T5017 |
400-408 |
JJ |
denotes |
clinical |
T96870 |
409-420 |
NN |
denotes |
improvement |
T42442 |
421-423 |
IN |
denotes |
of |
T61149 |
424-427 |
PDT |
denotes |
all |
T89276 |
428-431 |
DT |
denotes |
the |
T53728 |
432-435 |
CD |
denotes |
ten |
T50396 |
436-444 |
NNS |
denotes |
patients |
T59179 |
445-456 |
VBN |
denotes |
accompanied |
T83510 |
457-459 |
IN |
denotes |
by |
T2183 |
460-462 |
DT |
denotes |
an |
T4240 |
463-471 |
NN |
denotes |
increase |
T18383 |
472-474 |
IN |
denotes |
in |
T99269 |
475-485 |
NN |
denotes |
lymphocyte |
T12131 |
486-491 |
NN |
denotes |
count |
T36613 |
492-495 |
CC |
denotes |
and |
T91622 |
496-497 |
DT |
denotes |
a |
T39579 |
498-506 |
NN |
denotes |
decrease |
T72559 |
507-509 |
IN |
denotes |
in |
T31686 |
510-513 |
NN |
denotes |
CRP |
T20580 |
515-524 |
VBG |
denotes |
Following |
T23341 |
525-536 |
NN |
denotes |
transfusion |
T23846 |
537-539 |
IN |
denotes |
of |
T23496 |
540-552 |
JJ |
denotes |
convalescent |
T68740 |
553-559 |
NN |
denotes |
plasma |
T74721 |
559-560 |
-COMMA- |
denotes |
, |
T3255 |
561-564 |
PDT |
denotes |
all |
T47829 |
565-568 |
DT |
denotes |
the |
T16466 |
569-574 |
CD |
denotes |
seven |
T26913 |
575-583 |
NNS |
denotes |
patients |
T47643 |
584-587 |
WP |
denotes |
who |
T10299 |
588-592 |
VBD |
denotes |
were |
T19318 |
593-602 |
NN |
denotes |
SARS-CoV2 |
T2642 |
603-606 |
NN |
denotes |
RNA |
T76428 |
607-615 |
JJ |
denotes |
positive |
T59448 |
616-622 |
IN |
denotes |
before |
T49967 |
623-634 |
NN |
denotes |
transfusion |
T2352 |
635-637 |
IN |
denotes |
of |
T3020 |
638-650 |
JJ |
denotes |
convalescent |
T57517 |
651-657 |
NN |
denotes |
plasma |
T55829 |
658-664 |
VBD |
denotes |
turned |
T39392 |
665-674 |
NN |
denotes |
SARS-CoV2 |
T26456 |
675-683 |
JJ |
denotes |
negative |
T52249 |
685-690 |
EX |
denotes |
There |
T13795 |
691-695 |
VBD |
denotes |
were |
T15563 |
696-698 |
DT |
denotes |
no |
T53693 |
699-706 |
NN |
denotes |
control |
T35357 |
707-713 |
NNS |
denotes |
groups |
T16756 |
714-723 |
VBG |
denotes |
receiving |
T53621 |
724-736 |
JJ |
denotes |
convalescent |
T81904 |
737-743 |
NN |
denotes |
plasma |
T11852 |
744-749 |
RB |
denotes |
alone |
T58859 |
750-752 |
CC |
denotes |
or |
T35171 |
753-761 |
JJ |
denotes |
standard |
T39367 |
762-769 |
NN |
denotes |
therapy |
T20306 |
770-777 |
IN |
denotes |
without |
T63670 |
778-790 |
JJ |
denotes |
convalescent |
T44856 |
791-798 |
NN |
denotes |
therapy |
T15733 |
799-801 |
TO |
denotes |
to |
T71428 |
802-810 |
VB |
denotes |
evaluate |
T29390 |
811-814 |
DT |
denotes |
the |
T54708 |
815-819 |
JJ |
denotes |
main |
T64138 |
820-826 |
NN |
denotes |
effect |
T21425 |
827-829 |
IN |
denotes |
of |
T75685 |
830-842 |
JJ |
denotes |
convalescent |
T78861 |
843-849 |
NN |
denotes |
plasma |
R10830 |
T45118 |
T86655 |
arg1Of |
levels,antibody |
R11811 |
T44856 |
T20306 |
arg2Of |
therapy,without |
R11993 |
T22774 |
T85435 |
arg1Of |
recovered,from |
R12375 |
T2642 |
T10299 |
arg2Of |
RNA,were |
R12539 |
T22929 |
T50644 |
arg1Of |
agents,and |
R14919 |
T26456 |
T39392 |
arg1Of |
negative,SARS-CoV2 |
R17226 |
T80710 |
T48141 |
arg1Of |
plasma,can |
R19448 |
T2642 |
T19318 |
arg1Of |
RNA,SARS-CoV2 |
R20207 |
T57517 |
T3020 |
arg1Of |
plasma,convalescent |
R20951 |
T19573 |
T35997 |
arg1Of |
study,investigated |
R21152 |
T80710 |
T37520 |
arg1Of |
plasma,from |
R2179 |
T50571 |
T85435 |
arg2Of |
COVID-19,from |
R22133 |
T78861 |
T75685 |
arg1Of |
plasma,convalescent |
R22469 |
T64138 |
T21425 |
arg1Of |
effect,of |
R22614 |
T17217 |
T91679 |
arg2Of |
COVID-19,with |
R23710 |
T2642 |
T76428 |
arg1Of |
RNA,positive |
R24725 |
T26913 |
T10299 |
arg1Of |
patients,were |
R2474 |
T64138 |
T29390 |
arg1Of |
effect,the |
R25087 |
T23341 |
T20580 |
arg2Of |
transfusion,Following |
R2541 |
T50396 |
T59179 |
arg2Of |
patients,accompanied |
R26123 |
T16756 |
T20306 |
arg1Of |
receiving,without |
R27403 |
T93212 |
T48141 |
arg2Of |
treat,can |
R27767 |
T68740 |
T23496 |
arg1Of |
plasma,convalescent |
R28137 |
T80710 |
T77485 |
arg1Of |
plasma,Convalescent |
R29016 |
T16756 |
T15733 |
modOf |
receiving,to |
R2931 |
T49967 |
T2352 |
arg1Of |
transfusion,of |
R30054 |
T2522 |
T48589 |
arg1Of |
1,: |
R30096 |
T26913 |
T55829 |
arg1Of |
patients,turned |
R30895 |
T50396 |
T53728 |
arg1Of |
patients,ten |
R32394 |
T22929 |
T58621 |
arg1Of |
agents,anti-viral |
R32731 |
T38590 |
T37156 |
arg1Of |
safety,and |
R32883 |
T89053 |
T50644 |
arg2Of |
care,and |
R33735 |
T64138 |
T71428 |
arg2Of |
effect,evaluate |
R34116 |
T49329 |
T91601 |
arg1Of |
outcomes,of |
R34529 |
T10299 |
T59448 |
arg1Of |
were,before |
R36266 |
T26913 |
T16466 |
arg1Of |
patients,seven |
R3822 |
T57517 |
T2352 |
arg2Of |
plasma,of |
R38806 |
T4240 |
T2183 |
arg1Of |
increase,an |
R4008 |
T48589 |
T17226 |
arg2Of |
:,than |
R40479 |
T71443 |
T18696 |
arg2Of |
COVID-19,with |
R40530 |
T71428 |
T15733 |
arg1Of |
evaluate,to |
R40627 |
T37156 |
T94632 |
arg1Of |
and,of |
R40867 |
T7672 |
T83098 |
arg1Of |
study,showed |
R42101 |
T26913 |
T47643 |
arg1Of |
patients,who |
R42168 |
T55337 |
T23972 |
arg2Of |
11,[ |
R45762 |
T90182 |
T48589 |
arg2Of |
640,: |
R48507 |
T81904 |
T58859 |
arg1Of |
plasma,or |
R48725 |
T31686 |
T72559 |
arg2Of |
CRP,in |
R49718 |
T26913 |
T26456 |
arg1Of |
patients,negative |
R49789 |
T26913 |
T3255 |
arg1Of |
patients,all |
R49835 |
T35357 |
T53693 |
arg1Of |
groups,control |
R50628 |
T50396 |
T89276 |
arg1Of |
patients,the |
R50969 |
T26321 |
T17226 |
arg1Of |
higher,than |
R51409 |
T3048 |
T18696 |
arg1Of |
patients,with |
R51479 |
T50396 |
T61149 |
arg1Of |
patients,all |
R52082 |
T19573 |
T94687 |
arg1Of |
study,A |
R52864 |
T96870 |
T42442 |
arg1Of |
improvement,of |
R54555 |
T57657 |
T37520 |
arg2Of |
patients,from |
R5522 |
T3048 |
T91601 |
arg2Of |
patients,of |
R55615 |
T7672 |
T46997 |
arg1Of |
study,The |
R56320 |
T36613 |
T59179 |
arg1Of |
and,accompanied |
R56840 |
T64138 |
T54708 |
arg1Of |
effect,main |
R57108 |
T17217 |
T80666 |
arg1Of |
COVID-19,severe |
R57531 |
T39367 |
T35171 |
arg1Of |
therapy,standard |
R58957 |
T48589 |
T94835 |
arg1Of |
:,on |
R59105 |
T44856 |
T63670 |
arg1Of |
therapy,convalescent |
R60141 |
T49967 |
T59448 |
arg2Of |
transfusion,before |
R60332 |
T50644 |
T28925 |
arg2Of |
and,with |
R60391 |
T12131 |
T99269 |
arg1Of |
count,lymphocyte |
R61261 |
T45118 |
T26321 |
arg1Of |
levels,higher |
R63671 |
T48287 |
T91679 |
arg1Of |
patients,with |
R64658 |
T96870 |
T83098 |
arg2Of |
improvement,showed |
R65194 |
T19573 |
T22655 |
arg1Of |
study,pilot |
R65241 |
T81904 |
T53621 |
arg1Of |
plasma,convalescent |
R65706 |
T19573 |
T26265 |
arg1Of |
study,has |
R66056 |
T96870 |
T5017 |
arg1Of |
improvement,clinical |
R66336 |
T23341 |
T23846 |
arg1Of |
transfusion,of |
R66579 |
T26456 |
T55829 |
arg2Of |
negative,turned |
R67249 |
T37156 |
T95987 |
arg1Of |
and,contain |
R67798 |
T39579 |
T91622 |
arg1Of |
decrease,a |
R68506 |
T35357 |
T13795 |
arg2Of |
groups,were |
R69272 |
T24661 |
T37156 |
arg2Of |
effect,and |
R69387 |
T22929 |
T68950 |
arg1Of |
agents,regular |
R70060 |
T50396 |
T42442 |
arg2Of |
patients,of |
R70070 |
T52249 |
T13795 |
arg1Of |
There,were |
R70225 |
T45118 |
T95987 |
arg2Of |
levels,contain |
R7103 |
T58859 |
T16756 |
arg2Of |
or,receiving |
R72924 |
T57657 |
T22774 |
arg2Of |
patients,recovered |
R73729 |
T65134 |
T94632 |
arg2Of |
plasma,of |
R7377 |
T37156 |
T64844 |
arg1Of |
and,that |
R73941 |
T35997 |
T26265 |
arg2Of |
investigated,has |
R74118 |
T3048 |
T6238 |
arg1Of |
patients,ten |
R74990 |
T39367 |
T58859 |
arg2Of |
therapy,or |
R75573 |
T49329 |
T94835 |
arg2Of |
outcomes,on |
R75667 |
T80710 |
T93212 |
arg1Of |
plasma,treat |
R77420 |
T12131 |
T18383 |
arg2Of |
count,in |
R7749 |
T78861 |
T21425 |
arg2Of |
plasma,of |
R78448 |
T35997 |
T92410 |
arg1Of |
investigated,recently |
R7895 |
T65134 |
T56352 |
arg1Of |
plasma,convalescent |
R79010 |
T55829 |
T74721 |
arg1Of |
turned,"," |
R80186 |
T36613 |
T83510 |
arg2Of |
and,by |
R80215 |
T48287 |
T93212 |
arg2Of |
patients,treat |
R80896 |
T81904 |
T11852 |
arg1Of |
plasma,alone |
R82541 |
T39579 |
T72559 |
arg1Of |
decrease,in |
R83087 |
T37156 |
T35997 |
arg2Of |
and,investigated |
R83808 |
T55829 |
T20580 |
arg1Of |
turned,Following |
R84751 |
T89053 |
T22041 |
arg1Of |
care,supportive |
R85485 |
T39579 |
T36613 |
arg2Of |
decrease,and |
R87348 |
T89317 |
T28925 |
arg1Of |
combined,with |
R88677 |
T81264 |
T51845 |
arg1Of |
Rationale,4.1.1.2 |
R88768 |
T35357 |
T16756 |
arg1Of |
groups,receiving |
R90019 |
T71443 |
T93206 |
arg1Of |
COVID-19,severe |
R9016 |
T68740 |
T23846 |
arg2Of |
plasma,of |
R94657 |
T35357 |
T15563 |
arg1Of |
groups,no |
R95106 |
T19573 |
T23972 |
arg1Of |
study,[ |
R95339 |
T96728 |
T23972 |
arg3Of |
],[ |
R9567 |
T81264 |
T56248 |
arg1Of |
Rationale,: |
R95922 |
T4240 |
T36613 |
arg1Of |
increase,and |
R97536 |
T37156 |
T92380 |
arg1Of |
and,the |
R98083 |
T26913 |
T47829 |
arg1Of |
patients,the |
R98484 |
T49329 |
T20257 |
arg1Of |
outcomes,clinical |
R9880 |
T4240 |
T18383 |
arg1Of |
increase,in |
R9970 |
T48589 |
T89317 |
arg2Of |
:,combined |
R99734 |
T89053 |
T63224 |
arg1Of |
care,standard |